BLUE - bluebird bio, Inc.
IEX Last Trade
8.71
-0.040 -0.459%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$8.75
-0.04
-0.46%
Summary score
7%
Profitability
0%
Dept financing
14%
Liquidity
47%
Performance
1%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.35%
Return on assets
-11.86%
Return on sales
-17233.42%
Return on invested capital
-52.91%
Total debt ratio
41.7%
Debt ratio change over timeo
-1.36%
Current Ratio
3.62%
Quick Ratio
3.59%
Cash Position Ratio
3.33%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.76%
Return on assets
-13.17%
Return on sales
-32240.57%
Return on invested capital
-10.32%
Total debt ratio
58.39%
Debt ratio change over timeo
0.51%
Current Ratio
2.07%
Quick Ratio
2%
Cash Position Ratio
1.77%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-32.23%
Return on assets
-13.81%
Return on sales
-683.74%
Return on invested capital
-34.56%
Total debt ratio
63.73%
Debt ratio change over time
-2.84%
Current Ratio
1.55%
Quick Ratio
1.42%
Cash Position Ratio
1.1%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-27.23%
Return on assets
-81.36%
Return on sales
-29759.15%
Return on invested capital
42.7%
Total debt ratio
-135.61%
Debt ratio change over time
-1.36%
Current Ratio
-9.28%
Quick Ratio
-9.24%
Cash Position Ratio
-8.76%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BLUE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -22.35% | 7.58% | 36.15% | 7.75% |
| Return on assets | -11.86% | 2.95% | 3.44% | 5.85% |
| Return on sales | -17233.42% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | -52.91% | 3.7% | 6.05% | 20.44% |
| Profitability | 0% | 41% | 68% | 80% |
| Total debt ratio | 41.7% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | -1.36% | 292.67% | 15.45% | 1.02% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 2.07% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 2% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 1.77% | 0.3% | 1.72% | 2.75% |
| Liquididy | 71% | 19% | 29% | 64% |
| Short-term ratios | BLUE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.76% | 11.57% | 35.05% | 4.21% |
| Return on assets | -13.17% | 2.86% | 2.7% | 3.6% |
| Return on sales | -32240.57% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | -10.32% | 2.16% | 6.93% | 9.79% |
| Profitability | 0% | 54% | 85% | 78% |
| Total debt ratio | 58.39% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | 0.51% | 102.83% | 13.09% | 1.3% |
| Dept financing | 16% | 49% | 28% | 6% |
| Current Ratio | 2.07% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 2% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 1.77% | 0.3% | 1.72% | 2.75% |
| Liquididy | 37% | 12% | 40% | 75% |